Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

STE
STERIS plc
stock NYSE

At Close
Apr 29, 2026 3:59:55 PM EDT
212.69USD-3.213%(-7.06)810,488
0.00Bid   0.00Ask   0.00Spread
Pre-market
0.00USD-100.000%(-219.75)0
After-hours
Apr 29, 2026 4:00:30 PM EDT
212.65USD-0.019%(-0.04)2,236
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
04:30PM EST  STERIS plc (NYSE: STE) (STERIS or the Company) announced today that the Company will distribute a quarterly interim dividend of $0.43 per share. The dividend is payable March 24, 2022 to shareholders of record at the close of business on February 25, 2022.   GlobeNewswire Inc
Jan 25, 2022
04:30PM EST  STERIS to Host a Conference Call for Fiscal 2022 Third Quarter   GlobeNewswire Inc
Jan 3, 2022
04:19PM EST  Evoqua Water Technologies Closes Acquisition Of Renal Business From STERIS   RTTNews
Dec 21, 2021
07:01AM EST  OTC Markets Group Welcomes Starr Peak Mining Ltd. to OTCQX   PR Newswire
Dec 20, 2021
07:01AM EST  Evoqua Water Technologies Signs Definitive Agreement To Acquire Renal Business From STERIS For $196.3M   Benzinga
Dec 2, 2021
12:09PM EST  If You Invested $100 Over The Past 5 Years In This Stock, Here's How Much You Would Have Today   Benzinga
Nov 4, 2021
09:22AM EDT  Stephens & Co. Maintains Overweight on Steris, Raises Price Target to $270   Benzinga
04:40AM EDT  Keybanc Maintains Overweight on Steris, Raises Price Target to $256   Benzinga
Nov 2, 2021
05:40PM EDT  Steris Q2 EPS $1.99 Beats $1.82 Estimate, Sales $1.20B Beat $1.15B Estimate   Benzinga
05:14PM EDT  STERIS plc (STE) announced earnings for second quarter that decreased from the same period last year.   RTTNews
05:01PM EDT  STERIS Q2 EPS $0.69 Vs. $1.23 Year Ago   RTTNews
10:41AM EDT  Earnings Scheduled For November 2, 2021   Benzinga
Oct 20, 2021
04:30PM EDT  STERIS to Host a Conference Call for Fiscal 2022 Second Quarter   GlobeNewswire Inc
Aug 11, 2021
10:04AM EDT  A Look Into Steris Price Over Earnings   Benzinga
08:37AM EDT  Baird Maintains Outperform on Steris, Raises Price Target to $250   Benzinga
08:33AM EDT  Stephens & Co. Maintains Overweight on Steris, Raises Price Target to $255   Benzinga
04:41AM EDT  Keybanc Maintains Overweight on Steris, Raises Price Target to $239   Benzinga
Aug 9, 2021
04:35PM EDT  UPDATE: Steris Raises FY22 Sales Guidance From $4.5B To $4.6B vs $4.33B Estimate, Adj. EPS From $7.40-$7.65 To $7.60-$7.85 vs $7.41 Est.   Benzinga
04:33PM EDT  Steris Q1 Adj. EPS $1.76 Beats $1.51 Estimate, Sales $968.40M Beat $881.72M Estimate; Raises Guidance   Benzinga
04:11AM EDT  Earnings Scheduled For August 9, 2021   Benzinga
Jun 2, 2021
09:10AM EDT  STERIS Completes Acquisition Of Cantel Medical   RTTNews
09:00AM EDT  STERIS plc (NYSE: STE) (STERIS or the Company) today announced that it has completed the previously announced acquisition of Cantel Medical, a global provider of infection prevention products and services to endoscopy, dental, dialysis and life sciences Customers.   GlobeNewswire Inc
May 26, 2021
10:09AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2021   Benzinga
06:05AM EDT  Needham Upgrades Steris to Buy, Announces $233 Price Target   Benzinga
May 18, 2021
04:58PM EDT  Recap: Steris Q4 Earnings   Benzinga
04:45PM EDT  Steris Q4 EPS $1.63 May Not Compare To $1.77 Estimate, Sales $873.50M Miss $876.21M Estimate   Benzinga
04:34PM EDT  STERIS Sees FY22 EPS $7.40-$7.65 Vs $7 Estimates   Benzinga
04:32PM EDT  Steris Q4 EPS $1.64 May Not Compare To $1.77 Estimate, Sales $873.50M Miss $876.21M Estimate   Benzinga
04:30PM EDT  -- Fourth quarter revenue increases 6% as reported; full year increases 3% as reported -- Full year earnings per diluted share of $4.63 on a U.S. GAAP basis and $6.17 on an adjusted basis on effective tax rates of 23.3% and 20.7%, respectively -- Company provides outlook for fiscal 2022 includingCantel Medical   GlobeNewswire Inc
04:08AM EDT  Earnings Scheduled For May 18, 2021   Benzinga
May 17, 2021
10:08AM EDT  Preview: Steris's Earnings   Benzinga
May 11, 2021
04:30PM EDT  -- David B. Lewis to retire at the Companys 2021 Annual Meeting of Shareholders -- Company appoints Paul E. Martin to Board   GlobeNewswire Inc
10:46AM EDT  JMP Securities Maintains Market Outperform on Steris, Raises Price Target to $235   Benzinga
Apr 27, 2021
07:17AM EDT  STERIS Expects FY21 Sales ~$3.1B; Sees FY21 Income From Operations Of $548M   Benzinga
07:00AM EDT  -- Company expects to close the Cantel Medical acquisition by June 2, 2021, pending shareholder vote   GlobeNewswire Inc
Mar 11, 2021
05:14AM EST  KeyBanc Maintains Overweight on Steris, Raises Price Target to $227   Benzinga
Mar 9, 2021
07:02AM EST  Cantel Medical Q2 Net Sales $294.0 Mln, Up 1.9% From Last Year   RTTNews
07:01AM EST  Cantel Medical Reports Strong Financial Results for its Second Quarter Fiscal   PR Newswire
Feb 22, 2021
10:13AM EST  Understanding Steris's Ex-Dividend Date   Benzinga
Feb 9, 2021
03:37PM EST  Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cantel Medical Corp - CMD   PR Newswire
Feb 4, 2021
10:03AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2021   Benzinga
05:02AM EST  KeyBanc Upgrades Steris to Overweight, Announces $224 Price Target   Benzinga
Feb 3, 2021
07:10AM EST  STERIS Announces Walt Rosebrough To Step Down As CEO; Dan Carestio To Succeed As President And Ceo   Benzinga
07:00AM EST  -- Walt Rosebrough to step down as CEO at the upcoming Annual General Meeting -- Chief Operating Officer, Dan Carestio, to succeed as President and CEO   GlobeNewswire Inc
Feb 2, 2021
05:06PM EST  STERIS plc (STE) announced a profit for its third quarter that increased from last year.   RTTNews
04:48PM EST  Recap: Steris Q3 Earnings   Benzinga
04:33PM EST  STERIS Q3 EPS $1.33 Vs $1.23 Last Year   RTTNews
04:30PM EST  Steris Q3 Adj. EPS $1.73 Beats $1.52 Estimate, Sales $808.90M Beat $792.98M Estimate   Benzinga
04:30PM EST  -- Third quarter revenue increases 4% as reported; 1% constant currency organic -- Third quarter earnings per diluted share increase to $1.33 on a U.S. GAAP basis and $1.73 on an adjusted basis -- Increased free cash flow driven by net income growth and working capital improvements   GlobeNewswire Inc
04:00AM EST  Earnings Scheduled For February 2, 2021   Benzinga
Feb 1, 2021
10:06AM EST  A Preview Of Steris's Earnings   Benzinga
Jan 19, 2021
04:30PM EST  STERIS to Host a Conference Call for Fiscal 2021 Third Quarter   GlobeNewswire Inc
Jan 13, 2021
07:30PM EST  SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of   GlobeNewswire Inc
Jan 12, 2021
05:06PM EST  SHAREHOLDER ALERT: WeissLaw LLP Investigates Cantel Medical Corp.   PR Newswire
01:30PM EST  ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cantel Medical   PR Newswire
12:23PM EST  Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Cantel Medical Corp. (NYSE: CMD) breached their fiduciary duties or violated the federal securities laws in connection with the companys acquisition by STERIS plc (NYSE: STE).   GlobeNewswire Inc
07:37AM EST  STERIS plc (STE) agreed to buy Cantel Medical Corp (CMD) in a cash and stock transaction valued at $84.66 per Cantel common share. It represents a total equity value of about $3.6 billion and a total enterprise value of about $4.6 billion, including Cantel's net debt and convertible notes.   RTTNews
07:24AM EST  STERIS Agrees To Acquire Cantel For $84.66/Shr   RTTNews
07:14AM EST  STERIS Announces Definitive Agreement To Acquire Cantel Medical In cash And Stock Transaction Valued At $84.66/Cantel Common Share   Benzinga
07:13AM EST  -- Complementary to STERISs product and service portfolio, focused on infection prevention -- Extends STERISs reach to Dental Customers -- $110 million in expected EBIT synergies by year four -- Accretive to adjusted earnings per diluted share in year one -- Conference call with STERIS and Cantel management today at 8:00 a.m. ET   GlobeNewswire Inc
Jan 7, 2021
05:14PM EST  STERIS To Participate in Upcoming Investor Conferences   GlobeNewswire Inc
Nov 18, 2020
04:33PM EST  STERIS Completes the acquisition of Key Surgical.   Benzinga
04:30PM EST  STERIS plc (NYSE: STE) (STERIS or the Company) today announced that is has completed the previously announced acquisition of Key Surgical, a portfolio company of Water Street Healthcare Partners, LLC.   GlobeNewswire Inc
Nov 2, 2020
05:48PM EST  Steris plc (STE) Monday reported second-quarter net income of $105.9 million or $1.23 per share, up from $94.8 million or $1.11 per share last year.   RTTNews
04:48PM EST  Steris Q2 EPS $1.23 Vs. $.11 Year Ago   RTTNews
04:42PM EST  Steris Q2 EPS $1.48 Beats $1.27 Estimate, Sales $756.10M Beat $722.87M Estimate   Benzinga
04:30PM EST  -- Second quarter revenue increases 3% as reported; 2% constant currency organic -- Second quarter earnings per diluted share increase to $1.23 on a U.S. GAAP basis and $1.48 on an adjusted basis -- Increased cash flow driven by net income growth and working capital improvements   GlobeNewswire Inc
07:55AM EST  Earnings Scheduled For November 2, 2020   Benzinga
Oct 20, 2020
07:00AM EDT  STERIS to Host a Conference Call for Fiscal 2021 Second Quarter   GlobeNewswire Inc
Oct 6, 2020
08:05AM EDT  Steris plc (STE) announced Tuesday that it has signed a definitive agreement to purchase Key Surgical, a portfolio company of Water Street Healthcare Partners, LLC, through a U.S. subsidiary for $850 million.   RTTNews
07:51AM EDT  Steris PLC To Buy Key Surgical For $850 Mln   RTTNews
07:18AM EDT  STERIS To Acquire Key Surgical For ~$850M   Benzinga
07:00AM EDT  -- Consumable product portfolio a natural extension for STERISs Customers in sterile processing departments, operating rooms and endoscopy -- Compelling financial benefits - accretive to top-line growth, margins and earnings -- Expected to close by December 31, 2020 -- Conference call with STERIS Management today at 10:00 a.m. ET   GlobeNewswire Inc
Sep 2, 2020
06:00AM EDT  Baird Initiates Coverage On Steris with Outperform Rating, Announces Price Target of $175   Benzinga
Aug 3, 2020
05:56PM EDT  STERIS plc (STE) Monday reported first-quarter net income of $88.2 million or $1.03 per share, up from $84.6 million or $0.99 per share last year.   RTTNews
04:46PM EDT  Steris Q1 EPS $1.03 Vs. $0.99 Year Ago   RTTNews
04:42PM EDT  Steris Q1 Adj. EPS $1.31 Beats $0.96 Estimate, Sales $668.90M Beat $635.98M Estimate   Benzinga
04:30PM EDT  First quarter revenue declines low-single digits due to reduction in deferrable procedures First quarter net income grows low-single digits driven by margin expansion Board increases dividend for 15th consecutive year   GlobeNewswire Inc
04:13AM EDT  Earnings Scheduled For August 3, 2020   Benzinga
Jul 31, 2020
11:15AM EDT  Earnings Preview: Steris   Benzinga
Jul 22, 2020
04:30PM EDT  STERIS to Host a Conference Call for Fiscal 2021 First Quarter   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC